HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 58 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,227,287 | +3.2% | 98,483 | +10.9% | 0.00% | 0.0% |
| Q2 2023 | $3,125,786 | +18.8% | 88,826 | +10.2% | 0.00% | 0.0% |
| Q1 2023 | $2,631,786 | -41.5% | 80,606 | -1.3% | 0.00% | -50.0% |
| Q4 2022 | $4,497,978 | +29.1% | 81,633 | +3.8% | 0.00% | +100.0% |
| Q3 2022 | $3,484,000 | +18.2% | 78,680 | +30.2% | 0.00% | 0.0% |
| Q2 2022 | $2,947,000 | +15.8% | 60,428 | +15.5% | 0.00% | 0.0% |
| Q1 2022 | $2,545,000 | +13.4% | 52,307 | -0.6% | 0.00% | 0.0% |
| Q4 2021 | $2,245,000 | +812.6% | 52,629 | +717.5% | 0.00% | – |
| Q3 2021 | $246,000 | +179.5% | 6,438 | +107.8% | 0.00% | – |
| Q2 2021 | $88,000 | +319.0% | 3,098 | +391.0% | 0.00% | – |
| Q1 2021 | $21,000 | -8.7% | 631 | 0.0% | 0.00% | – |
| Q4 2020 | $23,000 | – | 631 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
| venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
| Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
| Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
| ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
| TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
| MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
| O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |